The Meaningful Participation of 'Stakeholders' in Global Drug Policy Debates—a Policy Comment [chapter]

2020 Drug Policies and Development  
This policy comment seeks to address three key questions relating to the participation of civil society in international drug policymaking. Firstly, who are the relevant 'stakeholders' and what options do they have to participate in drug policy discussions at
doi:10.1163/9789004440494_010 fatcat:c5xjxo7sqracnny5h4x7iwclzy